Read + Share
Amedeo Smart
Independent Medical Education
Dyer O. Aduhelm: Biogen abandons Alzheimer's drug after controversial approval left it unfunded by Medicare. BMJ 2024;384:q281.PMID: 38307520
Email
LinkedIn
Facebook
Twitter
Privacy Policy